MedTrace Logo

Diagnostic and Prognostic Biomarkers in SARS-CoV-2 Infections

NCT06774638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2025-01-14

No results posted yet for this study

Summary

Literature data document that SARS-CoV-2 RNA is present not only in the respiratory tract but also in the feces of infected patients, suggesting a potential additional route of transmission: the oro-fecal route. In this context, it becomes essential to have data on the use of serological tests in suspected SARS-CoV-2 patients and the presence of viral RNA in biological samples from affected patients, to quickly and reliably identify infected individuals and provide recommendations on the duration of patient isolation. In particular, such data could support the indication for contact isolation similar to that used for all highly contagious gastrointestinal infections, such as Clostridium difficile, with a longer duration than respiratory isolation. The objective of this study is to verify the presence of diagnostic and prognostic biomarkers in patients with SARS-CoV-2 infection.

Conditions

  • IBD - Inflammatory Bowel Disease
  • COVID - 19

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Paolo Gionchetti, MD · IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-04
Primary Completion
2021-12-31
Completion
2024-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06774638 on ClinicalTrials.gov